Related Experiment Videos
Auditory brain stem response results from 255 patients with suspected retrocochlear involvement
Ear and Hearing
|March 1, 1982
Summary
Auditory brain stem response (ABR) testing effectively identifies tumors in patients with suspected retrocochlear issues. However, ABR abnormalities also occur in non-tumor cases, often related to peripheral hearing loss.
Area of Science:
- Audiology
- Neuroscience
- Otolaryngology
Background:
- Retrocochlear pathologies can present with subtle auditory symptoms.
- Auditory Brainstem Response (ABR) is a key diagnostic tool for evaluating the auditory pathway beyond the cochlea.
Purpose of the Study:
- To assess the diagnostic utility of ABR in patients with suspected retrocochlear involvement.
- To differentiate ABR findings in tumor versus non-tumor cases.
Main Methods:
- Conducted ABR evaluations on 255 patients with suspected retrocochlear pathology.
- Correlated ABR results with surgical confirmation of tumors and other medical diagnoses.
Main Results:
- Surgically confirmed tumors were identified in 10% of patients, with 96% showing abnormal ABRs.
- 25% of patients with non-tumor diagnoses also exhibited ABR abnormalities.
- Common non-tumor ABR abnormalities included interaural latency differences, poor waveform resolution, and delayed wave V latency, potentially influenced by peripheral hearing loss.
Conclusions:
- ABR is highly sensitive for detecting tumors in suspected retrocochlear cases.
- ABR abnormalities are not exclusive to tumors and can be present in other conditions, notably peripheral hearing loss.
- Careful interpretation of ABR findings, considering peripheral hearing status, is crucial for accurate diagnosis.